Total Payments
$5,555
2024 Payments
$2,130
Companies
38
Transactions
258
Medicare Patients
6,898
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$5,534 (99.6%)
Other$20.42 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,534 | 257 | 99.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.42 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,209 | 73 | $0 (2024) |
| Celgene Corporation | $367.47 | 19 | $0 (2024) |
| Acorda Therapeutics, Inc | $311.97 | 11 | $0 (2024) |
| Eisai Inc. | $276.77 | 18 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $276.56 | 9 | $0 (2024) |
| Biogen, Inc. | $262.73 | 9 | $0 (2024) |
| SK Life Science, Inc. | $251.49 | 11 | $0 (2024) |
| UCB, Inc. | $247.46 | 11 | $0 (2024) |
| Lilly USA, LLC | $225.03 | 10 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $211.09 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,130 | 98 | ABBVIE INC. ($546.73) |
| 2023 | $1,322 | 69 | ABBVIE INC. ($395.71) |
| 2022 | $928.96 | 46 | ABBVIE INC. ($195.56) |
| 2021 | $553.70 | 29 | Eisai Inc. ($135.33) |
| 2020 | $310.71 | 7 | Sunovion Pharmaceuticals Inc. ($123.53) |
| 2019 | $235.23 | 4 | Acorda Therapeutics, Inc ($128.18) |
| 2018 | $74.18 | 5 | Allergan Inc. ($27.60) |
All Payment Transactions
258 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: Neurology | ||||||
| 12/18/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Immunology and Neurology | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/13/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/26/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/22/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/31/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Neurology | ||||||
| 10/26/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: Neurology | ||||||
| 10/22/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/14/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: Immunology | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: NEUROLOGY | ||||||
| 10/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,734 | 2,551 | $1.2M | $308,276 |
| 2022 | 20 | 1,885 | 2,781 | $1.4M | $347,634 |
| 2021 | 21 | 1,773 | 2,606 | $1.3M | $327,524 |
| 2020 | 21 | 1,506 | 2,138 | $982,797 | $245,399 |
Total Patients
6,898
Total Services
10,076
Medicare Billing
$1.2M
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 332 | 590 | $260,780 | $65,660 | 25.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 186 | 562 | $151,740 | $41,425 | 27.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 99 | 102 | $139,536 | $37,271 | 26.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 106 | 171 | $69,426 | $18,929 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 125 | 125 | $72,375 | $18,012 | 24.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 90 | 104 | $62,331 | $16,421 | 26.3% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 58 | 58 | $57,652 | $12,509 | 21.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 75 | 132 | $45,012 | $12,335 | 27.4% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 58 | 58 | $56,144 | $12,134 | 21.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 88 | 88 | $39,336 | $10,182 | 25.9% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 42 | 43 | $36,765 | $10,053 | 27.3% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2023 | 58 | 58 | $66,062 | $9,201 | 13.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 49 | 49 | $37,436 | $9,094 | 24.3% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 29 | 29 | $28,594 | $7,833 | 27.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 26 | 27 | $19,737 | $5,407 | 27.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 81 | 86 | $15,996 | $4,372 | 27.3% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 29 | 51 | $11,169 | $3,048 | 27.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $10,638 | $2,915 | 27.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 14 | $10,290 | $2,773 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 23 | 23 | $10,557 | $2,608 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 26 | $8,632 | $2,304 | 26.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 16 | 16 | $6,992 | $1,675 | 24.0% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 98 | 101 | $4,646 | $1,220 | 26.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 20 | $3,460 | $896.42 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 360 | 611 | $272,506 | $70,438 | 25.8% |
About Dr. Bruce Mayerson, MD
Dr. Bruce Mayerson, MD is a Neurology healthcare provider based in Smithtown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477657666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Mayerson, MD has received a total of $5,555 in payments from pharmaceutical and medical device companies, with $2,130 received in 2024. These payments were reported across 258 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,534).
As a Medicare-enrolled provider, Mayerson has provided services to 6,898 Medicare beneficiaries, totaling 10,076 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Smithtown, NY
- Active Since 09/11/2006
- Last Updated 05/28/2014
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1477657666
Products in Payments
- UBRELVY (Drug) $472.35
- BOTOX (Biological) $464.74
- ZEPOSIA (Drug) $367.47
- QULIPTA (Drug) $359.15
- INBRIJA (Drug) $311.97
- INGREZZA (Drug) $254.46
- NUPLAZID (Drug) $191.70
- Aduhelm (Drug) $175.05
- APTIOM (Drug) $172.80
- Rystiggo (Drug) $168.76
- EMGALITY (Drug) $157.33
- VYEPTI (Biological) $144.85
- AMPLATZER TALISMAN (Device) $142.83
- VUMERITY (Drug) $140.36
- NURTEC ODT (Drug) $131.68
- ADUHELM (Biological) $122.37
- Gamunex-C (Biological) $98.92
- COMIRNATY (Biological) $97.26
- AUBAGIO (Drug) $96.88
- Cardiac Monitoring Suite (Device) $92.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Smithtown
Mark Zuckerman, Md, MD
Neurology — Payments: $14,411
Neurology $14,411
Dr. Schenley Que, Md, MD
Neurology — Payments: $5,894
Neurology $5,894
Dr. Richard Pearl, Md, MD
Neurology — Payments: $152.32
Neurology $152.32
Dr. Mathew Chacko, Md, MD
Neurology — Payments: $108.49
Neurology $108.49
Harpreet Khurana, Md, MD
Neurology — Payments: $71.43
Neurology $71.43
Dr. Arvind Chopra, M.d, M.D
Neurology
Neurology